The Structural Disease Center

Filter Your Results




Phase 2 of Neovasc's TIARA-II Study to Commence in Germany and the United Kingdom

January 29, 2019 -- Neovasc Inc. announced that it has completed the phase 1 requirements of the TIARA-II study required by the biphasic study design in both Germany and the U…

Study Analyzes Predictive Value of EuroSCOREs in TAVR

January 29, 2019 -- Online in Circulation: Cardiovascular Interventions, Giuseppe Tarantini, MD, et al published findings from an evaluation of 1-year outcomes according to su…

Poor Outcomes Seen in Patients Ineligible for TMVR

January 29, 2019 -- Findings from an investigation of the causes and clinical outcomes of patients who are ineligible for transcatheter mitral valve replacement (TMVR) were pu…

Swiss Registry Analyzes Prognostic Relevance of Tei Index for Left Ventricular Myocardial Performance in TAVR

January 22, 2019 -- Tei, the left ventricular myocardial performance index, is associated with impaired clinical outcomes during short- and longer-term follow-up after transca…

Midterm Results Published From the International TriValve Registry

January 22, 2019 -- Midterm results from the International Multisite Transcatheter Tricuspid Valve Therapies registry (TriValve registry) were published by Maurizio Taramasso,…

Abbott's Amplatzer Piccolo Occluder Approved to Treat Patent Ductus Arteriosus in Premature Babies and Newborns

January 14, 2019 -- Abbott Structural Heart announced that the FDA has approved the company's Amplatzer Piccolo occluder, which can be implanted in very small babies (weig…

FDA Approves Edwards’ Sapien 3 Ultra TAVR System

January 4, 2019 -- Edwards Lifesciences announced FDA approval for its Sapien 3 Ultra system for transcatheter aortic valve replacement (TAVR) in patients with severe symptoma…

Venus Medtech and Keystone Heart Complete Merger

December 27, 2018 -- Venus Medtech announced it has completed its merger with Keystone Heart, Ltd. Venus Medtech is a leading transcatheter heart valve company in China. Keyst…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.